HVOI-T 0 CACB-T -0.03 XYL-N 1.13 FTS-T 0.38 CNR-T 0.24 ZRE-T 0.17
VSM MedTech Ltd. (VSM-T)

VSM MedTech Ltd. (VSM-T)

0.00
-0.00 (0.00%)
0 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0

Related posts

Nervous markets await Nvidia
DON'T BUY

VSM MedTech Ltd.(VSM-T)

Apr 21, 2014

Likes this. Core business is selling broadcast equipment to cable and telcos. Have done a great job of creating shareholder value by selling off non-core assets such as wireless spectrum and real estate in Saskatchewan. Thinks they are kind of getting to the end of the line and he has sold his position.

James HodginsJames Hodgins
No
Unlock Rating
$0.050

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

VSM MedTech Ltd.(VSM-T)

Aug 18, 2006
Recently entered into a financing agreement. Cash strapped. Existing shareholders tend to get totally diluted of their positions.
Robert FloydRobert Floyd
No
Unlock Rating
$0.090

Stock price when the opinion was issued

biotechnology pharmaceutical
SELL

VSM MedTech Ltd.(VSM-T)

Jul 25, 2006
Ranks near the bottom. Earnings have been shaved by 23%. Recent financing was very dilutive.
Robert McWhirterRobert McWhirter
No
Unlock Rating
$0.070

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

VSM MedTech Ltd.(VSM-T)

May 04, 2006
Ranks in the bottom 1% of his database. Earnings estimates have been revised downwards 12% in the last 90 days.
Robert McWhirterRobert McWhirter
No
Unlock Rating
$0.475

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

VSM MedTech Ltd.(VSM-T)

Mar 13, 2006
It is interesting technology. The company is suffering. Give it a pass. He has owned in the past.
Robert McWhirterRobert McWhirter
No
Unlock Rating
$0.530

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

VSM MedTech Ltd.(VSM-T)

Dec 08, 2005
Has very good technology, but unfortunately it is still in the early stages of being rolled out to the medical community. In the bottom 15% of his database. Earnings estimates have been shaved by about 5% in the last 90 days and 20% in the last 60 days. Most recent quarter had a negative earnings surprise. Expected to lose $0.23 in ’06 and $0.15 in ’07.
Robert McWhirterRobert McWhirter
No
Unlock Rating
$0.700

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

VSM MedTech Ltd.(VSM-T)

May 31, 2005
(A Top Pick Nov 19/03. Down 83%.) Stock did very well for a whle, but the company was not able to make a viable business. Sold off a long time ago.
Brendan KyneBrendan Kyne
No
Unlock Rating
$0.560

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

VSM MedTech Ltd.(VSM-T)

Apr 07, 2005
A tough one because the company is struggling with a management team that is being paid too much. Not doing well from a sales point of view and one of their competitors is starting to give away products as a bundling package.
Peter HodsonPeter Hodson
No
Unlock Rating
$0.600

Stock price when the opinion was issued

biotechnology pharmaceutical
TRADE

VSM MedTech Ltd.(VSM-T)

Feb 02, 2005
The bane of his existence. Comes back to haunt him. Has not got this one right at all.
David Taylor, MBA, CFADavid Taylor, MBA, CFA
Owned
Unlock Rating
$0.900

Stock price when the opinion was issued

biotechnology pharmaceutical
TRADE

VSM MedTech Ltd.(VSM-T)

Jan 14, 2005
Have had a lot of trouble. Lost their CEO. Have to do more research with management before investing. Have some interesting technology. Starting to look interesting.
Scott MorrisonScott Morrison
No
Unlock Rating
$1.040

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

VSM MedTech Ltd.(VSM-T)

Dec 20, 2004
Likes the company and their technology. Management team is improving operations, but they get paid way too much money. The question is; are they going to increase their sales base and ultimately sell the company or dwindle as a small cap. Under $1 there's not a whole lot of risk.
Peter HodsonPeter Hodson
No
Unlock Rating
$0.940

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

VSM MedTech Ltd.(VSM-T)

Dec 09, 2004
Not expected to earn any money. In the bottom 2% of the database. Year over year sales are down 43% and earnings down 71%.
Robert McWhirterRobert McWhirter
No
Unlock Rating
$0.670

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

VSM MedTech Ltd.(VSM-T)

Nov 12, 2004
CFO is gone and they have laid off the COO. Have sold zero units of their new technology. Running out of cash.
Duncan StewartDuncan Stewart
No
Unlock Rating
$0.690

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY ON WEAKNESS

VSM MedTech Ltd.(VSM-T)

Nov 04, 2004
Have been looking at it. Been beaten up more than it should be. Entering tax-loss selling season, so it could drop further. Still believes in the technology. New management could make a difference.
Peter HodsonPeter Hodson
No
Unlock Rating
$0.900

Stock price when the opinion was issued

biotechnology pharmaceutical
WAIT

VSM MedTech Ltd.(VSM-T)

Sep 24, 2004
Short term, it won't be good. Expect some tax loss selling in the last quarter. May take 3/4 years to get a big bang. Good product.
Peter HodsonPeter Hodson
No
Unlock Rating
$1.460

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 15 of 58 entries
Next PageNext Page

VSM MedTech Ltd.(VSM-T) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for VSM MedTech Ltd. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

VSM MedTech Ltd.(VSM-T) Frequently Asked Questions

What is VSM MedTech Ltd. stock symbol?

VSM MedTech Ltd. is a OTC stock, trading under the symbol VSM-T on the (). It is usually referred to as or VSM-T

Is VSM MedTech Ltd. a buy or a sell?

In the last year, there was no coverage of VSM MedTech Ltd. published on Stockchase.

Is VSM MedTech Ltd. a good investment or a top pick?

VSM MedTech Ltd. was recommended as a Top Pick by on . Read the latest stock experts ratings for VSM MedTech Ltd..

Why is VSM MedTech Ltd. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is VSM MedTech Ltd. worth watching?

In the last year 0 stock analysts on Stockchase covered VSM MedTech Ltd.. The stock is worth watching.

What is VSM MedTech Ltd. stock price?

On , VSM MedTech Ltd. (VSM-T) stock closed at a price of $.

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

CELH-Q 0.5$46.39
ORCL-N 8.39$218.63
HOOD-Q 10.6$93.63
GIS-N 1.29$51.81
QMAX-T -0.24$21.3

Today's Top Picks

HVOI-T 0$12.9
CACB-T -0.03$20.11
XYL-N 1.13$129.36
FTS-T 0.38$65.02
CNR-T 0.24$141.89

Popular Articles

Latest Sell Signals

HAI-T 0.49$5
HPYT-T -0.08$9.03
VGG-T -0.19$94.97
ZEB-T 0.36$45.73
SMAX-T -0.19$18.75

Most Recent Experts

Larry Berman CFA, CMT, CTA

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase Insights

Stockchase Insights

5i Research

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Chris Heakes

Chris Heakes

Harvest Portfolios

Christine Poole

Christine Poole

Davis Rea

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica